Press Releases

Magnify Magazine

Media Resources

Press Releases

microscope

Magnify Magazine

microscope

Media Resources

microscope

Best Companies to Work For logo

 December 8, 2021 ARUP Earns Fourth Consecutive Utah Business Best Companies to Work For Award

For the fourth consecutive year, Utah Business magazine has honored ARUP Laboratories with its Best Companies to Work For award. ARUP is one of 65 companies to earn the award.

Whole genome sequencing

Whole genome HiFi sequencing will be used on unexplained rare disease cases to evaluate if it can identify variants not readily detectable by short-read sequencing.

 November 18, 2021 PacBio and ARUP Laboratories Collaborate in a Study to Improve Rare Disease Diagnosis

PacBio and ARUP Laboratories announced they are collaborating on a study intended to evaluate whether the solve rate for rare disease cases can be increased.

A man empties recyclables into a recycling bin

 November 12, 2021 Recycling Coalition of Utah Names ARUP the Thomas A. Martin Business Recycler of the Year

The Recycling Coalition of Utah (RCU) honored ARUP with its Thomas A. Martin Business Recycler of the Year Award in recognition of the company’s recycling program efforts.

Stacks of quarters, ranging from smallest to largest, arup minimum wage increase

 October 26, 2021 ARUP Increases Its Minimum Hourly Wage to $15 and Raises Pay for All Hourly Employees

ARUP Laboratories announced that it will increase its minimum hourly wage to $15 , marking an important milestone in the company’s multiyear effort to increase wages for all employees.

Dr. Tracy George stands in a laboratory. She smiles at the camera.

President and Chief Medical Officer Tracy George, MD, worked with ARUP’s PharmaDX and Clinical Trials group to create the central pathology review offering used in clinical trials for AYVAKIT. The new precision therapy for advanced systemic mastocytosis recently earned approval from the U.S. Food and Drug Administration.

 July 2, 2021 ARUP’s Clinical Trials Group Lauds FDA Approval of New Precision Therapy to Treat Advanced Systemic Mastocytosis

The FDA recently approved a new precision therapy developed by Blueprint Medicines for adults with advanced systemic mastocytosis, a rare and potentially fatal hematologic malignancy.

Adam Baker stands in a laboratory. He smiles at the camera.

Adam Barker, PhD, has been named ARUP’s first chief scientific officer. He moves into the role after having spent four years as director of Research and Development.

 July 1, 2021 ARUP Appoints Adam Barker, PhD, to Lead Its New Technologies Group

Adam Barker, PhD, has been appointed as ARUP’s chief scientific officer, a role in which he will lead the newly formed New Technologies Group.